Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies.
Official registry: https://clinicaltrials.gov/study/NCT02418442 · Duke University · enrollment listed as 20,000
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 20,000 people at 82 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Primary outcome (registry wording): Prospectively collect essential data elements from children, adolescents and young adults with pediatric rheumatic diseases
Who it is for (from inclusion criteria)
- Ages any to 21 Years
- Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A)
- Subject and/or parent/legal guardian is willing to be contacted in the future by study staff
Who the registry excludes
- 1\. Greater than 21 years of age at the time of enrollment
Public study contact (from the registry)
Mara L Becker, MD, MSCE
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
82 listed- University of Alabama at Birmingham — Birmingham, Alabama (recruiting)
- Phoenix Children's Hospital — Phoenix, Arizona (recruiting)
- Children's Hospital of Los Angeles — Los Angeles, California (not_yet_recruiting)
- Mattel Children's Hospital at University of California Los Angeles — Los Angeles, California (recruiting)
- Stanford University Medical Center — Palo Alto, California (recruiting)
- Rady Children's Hospital San Diego — San Diego, California (recruiting)
- University of California at San Francisco Medical Center — San Francisco, California (recruiting)
- The Children's Hospital of Colorado — Aurora, Colorado (recruiting)
- Connecticut Children's Medical Center — Hartford, Connecticut (recruiting)
- Yale University — New Haven, Connecticut (terminated)
- Childrens National Medical Center — Washington D.C., District of Columbia (recruiting)
- University of Florida - Shand's Children's Hospital — Gainesville, Florida (recruiting)
+ 7 sites outside the US on the same record
FAQ about this NCT record
Is NCT02418442 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT02418442?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT02418442?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary